ReviewTranslational lung cancer research2013

KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach.

Javier de Castro Carpeño et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.